UK markets open in 4 hours 9 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,460.19 +253.06 (+1.39%) CRUDE OIL
79.09 +0.14 (+0.18%) GOLD FUTURES
2,310.80 +1.20 (+0.05%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,490.52 +1,710.51 (+3.74%)
Daiichi Sankyo Company, Limited (4568.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
Loading interactive chart…
- Business Wire
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial
TOKYO & BASKING RIDGE, N.J., April 29, 2024--ENHERTU Showed Statistically Significant & Clinically Meaningful Improvement in PFS in HR Positive, HER2 Low mBC Following ET in DESTINY-Breast06
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- Zacks
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
© 2024 Yahoo. All rights reserved.